Astria Therapeutics, Inc.
SEC Document
SEC Filing

At the Annual Meeting, the Company’s stockholders approved an amendment to the Company’s Restated Certificate of Incorporation (the “Certificate of Incorporation”) to expand the director exculpation provision to include exculpation of certain of the Company's senior corporate officers, subject to specified limitations, as permitted by a recent amendment to the Delaware General Corporation Law (the “Charter Amendment”). The Company filed a Certificate of Amendment, which was effective upon filing, with the Secretary of State of the State of Delaware on June 5, 2023 to effect the Charter Amendment (the “Certificate of Amendment”).